Pre-symptomatic testing for neurodegenerative disorders: Middle- to long-term psychopathological impact

Background: Over the past 20 years, studies have revealed that the communication of a pre-symptomatic test (PST) result for late-onset diseases, such as Huntington's disease (HD), doesn't cause psychological disturbance. This cross-sectional study investigated the middle- (4 years) to long...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Psicothema 2017-10, Vol.29 (4), p.446
Hauptverfasser: Ledo, Susana, Leite, Angela, Souto, Teresa, Dinis, Maria Alzira Pimenta, Sequeiros, Jorge
Format: Artikel
Sprache:spa
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 4
container_start_page 446
container_title Psicothema
container_volume 29
creator Ledo, Susana
Leite, Angela
Souto, Teresa
Dinis, Maria Alzira Pimenta
Sequeiros, Jorge
description Background: Over the past 20 years, studies have revealed that the communication of a pre-symptomatic test (PST) result for late-onset diseases, such as Huntington's disease (HD), doesn't cause psychological disturbance. This cross-sectional study investigated the middle- (4 years) to long-term (7 and 10 years) psychological impact of PST for 3 autosomal dominant late-onset diseases: HD, Machado-Joseph disease (DMJ) and familial amyloid polyneuropathy (FAP). Method: The study included 203 subjects: 170 (84%) agreed to make the PST for FAP, 29 (14%) for HD and 4 (2%) for MJD. They were mostly women (58%) and married (67%). It was considered the cutoffs points: 4 years (middle-term) and 7 and 10 years (long-term) indicating the time after receiving the TPS results. Results: women and widows (oldest) presented the highest mean values for almost all BSI dimensions and the highest values correspond to the obsessive-compulsive dimension. MJD participants presented the highest mean values. No differences were found concerning the PST test results while participants are still asymptomatic. Psychopathology was only present in symptomatic carriers. Conclusions: The onset of the disease seems to assume the trigger for psychological disturbance, regardless the time that has elapsed since the PST result communication or the individual carrier/non-carrier condition. Keywords: Pre-symptomatic testing, psychological impact, late-onset genetic diseases. Pruebas pre-sintomaticas de enfermedades neurodegenerativas: el impacio psicopatologico a largo plazo. Antecedentes: el presente estudio transversal investigo el impacto psicopatologico a medio (4 anos) y a largo plazo (7 y 10 anos) de la prueba pre-sintomatica (PPS) para tres enfermedades autosomicas dominantes de aparicion tardia: enfermedad de Huntington EH, la enfermedad de Machado-Joseph (EMJ) y la polineuropatia amiloide familiar (PAF). Metodo: participaron 203 sujetos: 170 (84%) realizaron el PPS para PAF, 29 (14%) para EH y 4 (2 %) para EMJ. La muestra, en su mayoria, estuvo compuesta por mujeres (58%) y por personas casadas (67%). Fueron considerados como puntos de corte los 4, 7 y 10 anos despues de haber recibido el resultado de la PPS. Resultados: las mujeres y los viudos presentan las medias mas altas. Los participantes con EMJ presentaron las medias mas elevadas. No se encontraron diferencias significativas en lo concerniente a los resultados de PPS. La perturbacion psicologica fue escasamente observada en los
doi_str_mv 10.7334/psicothema2016.298
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracacademiconefile_A517625950</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A517625950</galeid><sourcerecordid>A517625950</sourcerecordid><originalsourceid>FETCH-gale_infotracacademiconefile_A5176259503</originalsourceid><addsrcrecordid>eNqVjj1KBTEUhVMo-PzZgFU2kDHJvMw4diKKjWBhLyG5k4kkuSG5Cm_3TuEG5BQHvsMHh7FbJYd5HI93tUeHtEG2Wqpp0Mv9GTtIrY5iWZS5YJe9f0lppnHWBxbeG4h-ypUwW4qOE3SKJfAVGy_w3dBDgAJtH3-A-9ixeWj9gb9F7xMITsgTliAIWua1n9yG1dKGCUN0NvGYq3V0zc5Xmzrc_PUVG16eP55eRbAJPmNZkZp1ezzk_X6BNe780ah50mYxcvy38AumaFf3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pre-symptomatic testing for neurodegenerative disorders: Middle- to long-term psychopathological impact</title><source>ProQuest Central Essentials</source><source>Research Library</source><source>ProQuest Central (Alumni Edition)</source><source>DOAJ Directory of Open Access Journals</source><source>ProQuest Central Student</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Research Library (Alumni Edition)</source><source>Research Library Prep</source><source>ProQuest Central Korea</source><source>ProQuest Central UK/Ireland</source><source>ProQuest Central</source><creator>Ledo, Susana ; Leite, Angela ; Souto, Teresa ; Dinis, Maria Alzira Pimenta ; Sequeiros, Jorge</creator><creatorcontrib>Ledo, Susana ; Leite, Angela ; Souto, Teresa ; Dinis, Maria Alzira Pimenta ; Sequeiros, Jorge</creatorcontrib><description>Background: Over the past 20 years, studies have revealed that the communication of a pre-symptomatic test (PST) result for late-onset diseases, such as Huntington's disease (HD), doesn't cause psychological disturbance. This cross-sectional study investigated the middle- (4 years) to long-term (7 and 10 years) psychological impact of PST for 3 autosomal dominant late-onset diseases: HD, Machado-Joseph disease (DMJ) and familial amyloid polyneuropathy (FAP). Method: The study included 203 subjects: 170 (84%) agreed to make the PST for FAP, 29 (14%) for HD and 4 (2%) for MJD. They were mostly women (58%) and married (67%). It was considered the cutoffs points: 4 years (middle-term) and 7 and 10 years (long-term) indicating the time after receiving the TPS results. Results: women and widows (oldest) presented the highest mean values for almost all BSI dimensions and the highest values correspond to the obsessive-compulsive dimension. MJD participants presented the highest mean values. No differences were found concerning the PST test results while participants are still asymptomatic. Psychopathology was only present in symptomatic carriers. Conclusions: The onset of the disease seems to assume the trigger for psychological disturbance, regardless the time that has elapsed since the PST result communication or the individual carrier/non-carrier condition. Keywords: Pre-symptomatic testing, psychological impact, late-onset genetic diseases. Pruebas pre-sintomaticas de enfermedades neurodegenerativas: el impacio psicopatologico a largo plazo. Antecedentes: el presente estudio transversal investigo el impacto psicopatologico a medio (4 anos) y a largo plazo (7 y 10 anos) de la prueba pre-sintomatica (PPS) para tres enfermedades autosomicas dominantes de aparicion tardia: enfermedad de Huntington EH, la enfermedad de Machado-Joseph (EMJ) y la polineuropatia amiloide familiar (PAF). Metodo: participaron 203 sujetos: 170 (84%) realizaron el PPS para PAF, 29 (14%) para EH y 4 (2 %) para EMJ. La muestra, en su mayoria, estuvo compuesta por mujeres (58%) y por personas casadas (67%). Fueron considerados como puntos de corte los 4, 7 y 10 anos despues de haber recibido el resultado de la PPS. Resultados: las mujeres y los viudos presentan las medias mas altas. Los participantes con EMJ presentaron las medias mas elevadas. No se encontraron diferencias significativas en lo concerniente a los resultados de PPS. La perturbacion psicologica fue escasamente observada en los sujetos portadores que ya evidenciaban sintomas. Conclusiones: la aparicion de los primeras sintomas parece constituir el detonante para la existencia de perturbaciones psicologicas, independientemente del intervalo de tiempo sucedido desde la comunicacion de los resultados de la PPS o de la condicion genetica (portador/no portador). Palabras clave: prueba pre-sintomatica, impacto psicopatologico. enfermedades geneticas de aparicion tardia.</description><identifier>ISSN: 0214-9915</identifier><identifier>DOI: 10.7334/psicothema2016.298</identifier><language>spa</language><publisher>Colegio Oficial De Psicologos Del Principado De Asturias</publisher><ispartof>Psicothema, 2017-10, Vol.29 (4), p.446</ispartof><rights>COPYRIGHT 2017 Colegio Oficial De Psicologos Del Principado De Asturias</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,861,27905,27906</link.rule.ids></links><search><creatorcontrib>Ledo, Susana</creatorcontrib><creatorcontrib>Leite, Angela</creatorcontrib><creatorcontrib>Souto, Teresa</creatorcontrib><creatorcontrib>Dinis, Maria Alzira Pimenta</creatorcontrib><creatorcontrib>Sequeiros, Jorge</creatorcontrib><title>Pre-symptomatic testing for neurodegenerative disorders: Middle- to long-term psychopathological impact</title><title>Psicothema</title><description>Background: Over the past 20 years, studies have revealed that the communication of a pre-symptomatic test (PST) result for late-onset diseases, such as Huntington's disease (HD), doesn't cause psychological disturbance. This cross-sectional study investigated the middle- (4 years) to long-term (7 and 10 years) psychological impact of PST for 3 autosomal dominant late-onset diseases: HD, Machado-Joseph disease (DMJ) and familial amyloid polyneuropathy (FAP). Method: The study included 203 subjects: 170 (84%) agreed to make the PST for FAP, 29 (14%) for HD and 4 (2%) for MJD. They were mostly women (58%) and married (67%). It was considered the cutoffs points: 4 years (middle-term) and 7 and 10 years (long-term) indicating the time after receiving the TPS results. Results: women and widows (oldest) presented the highest mean values for almost all BSI dimensions and the highest values correspond to the obsessive-compulsive dimension. MJD participants presented the highest mean values. No differences were found concerning the PST test results while participants are still asymptomatic. Psychopathology was only present in symptomatic carriers. Conclusions: The onset of the disease seems to assume the trigger for psychological disturbance, regardless the time that has elapsed since the PST result communication or the individual carrier/non-carrier condition. Keywords: Pre-symptomatic testing, psychological impact, late-onset genetic diseases. Pruebas pre-sintomaticas de enfermedades neurodegenerativas: el impacio psicopatologico a largo plazo. Antecedentes: el presente estudio transversal investigo el impacto psicopatologico a medio (4 anos) y a largo plazo (7 y 10 anos) de la prueba pre-sintomatica (PPS) para tres enfermedades autosomicas dominantes de aparicion tardia: enfermedad de Huntington EH, la enfermedad de Machado-Joseph (EMJ) y la polineuropatia amiloide familiar (PAF). Metodo: participaron 203 sujetos: 170 (84%) realizaron el PPS para PAF, 29 (14%) para EH y 4 (2 %) para EMJ. La muestra, en su mayoria, estuvo compuesta por mujeres (58%) y por personas casadas (67%). Fueron considerados como puntos de corte los 4, 7 y 10 anos despues de haber recibido el resultado de la PPS. Resultados: las mujeres y los viudos presentan las medias mas altas. Los participantes con EMJ presentaron las medias mas elevadas. No se encontraron diferencias significativas en lo concerniente a los resultados de PPS. La perturbacion psicologica fue escasamente observada en los sujetos portadores que ya evidenciaban sintomas. Conclusiones: la aparicion de los primeras sintomas parece constituir el detonante para la existencia de perturbaciones psicologicas, independientemente del intervalo de tiempo sucedido desde la comunicacion de los resultados de la PPS o de la condicion genetica (portador/no portador). Palabras clave: prueba pre-sintomatica, impacto psicopatologico. enfermedades geneticas de aparicion tardia.</description><issn>0214-9915</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqVjj1KBTEUhVMo-PzZgFU2kDHJvMw4diKKjWBhLyG5k4kkuSG5Cm_3TuEG5BQHvsMHh7FbJYd5HI93tUeHtEG2Wqpp0Mv9GTtIrY5iWZS5YJe9f0lppnHWBxbeG4h-ypUwW4qOE3SKJfAVGy_w3dBDgAJtH3-A-9ixeWj9gb9F7xMITsgTliAIWua1n9yG1dKGCUN0NvGYq3V0zc5Xmzrc_PUVG16eP55eRbAJPmNZkZp1ezzk_X6BNe780ah50mYxcvy38AumaFf3</recordid><startdate>20171001</startdate><enddate>20171001</enddate><creator>Ledo, Susana</creator><creator>Leite, Angela</creator><creator>Souto, Teresa</creator><creator>Dinis, Maria Alzira Pimenta</creator><creator>Sequeiros, Jorge</creator><general>Colegio Oficial De Psicologos Del Principado De Asturias</general><scope/></search><sort><creationdate>20171001</creationdate><title>Pre-symptomatic testing for neurodegenerative disorders: Middle- to long-term psychopathological impact</title><author>Ledo, Susana ; Leite, Angela ; Souto, Teresa ; Dinis, Maria Alzira Pimenta ; Sequeiros, Jorge</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-gale_infotracacademiconefile_A5176259503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ledo, Susana</creatorcontrib><creatorcontrib>Leite, Angela</creatorcontrib><creatorcontrib>Souto, Teresa</creatorcontrib><creatorcontrib>Dinis, Maria Alzira Pimenta</creatorcontrib><creatorcontrib>Sequeiros, Jorge</creatorcontrib><jtitle>Psicothema</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ledo, Susana</au><au>Leite, Angela</au><au>Souto, Teresa</au><au>Dinis, Maria Alzira Pimenta</au><au>Sequeiros, Jorge</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pre-symptomatic testing for neurodegenerative disorders: Middle- to long-term psychopathological impact</atitle><jtitle>Psicothema</jtitle><date>2017-10-01</date><risdate>2017</risdate><volume>29</volume><issue>4</issue><spage>446</spage><pages>446-</pages><issn>0214-9915</issn><abstract>Background: Over the past 20 years, studies have revealed that the communication of a pre-symptomatic test (PST) result for late-onset diseases, such as Huntington's disease (HD), doesn't cause psychological disturbance. This cross-sectional study investigated the middle- (4 years) to long-term (7 and 10 years) psychological impact of PST for 3 autosomal dominant late-onset diseases: HD, Machado-Joseph disease (DMJ) and familial amyloid polyneuropathy (FAP). Method: The study included 203 subjects: 170 (84%) agreed to make the PST for FAP, 29 (14%) for HD and 4 (2%) for MJD. They were mostly women (58%) and married (67%). It was considered the cutoffs points: 4 years (middle-term) and 7 and 10 years (long-term) indicating the time after receiving the TPS results. Results: women and widows (oldest) presented the highest mean values for almost all BSI dimensions and the highest values correspond to the obsessive-compulsive dimension. MJD participants presented the highest mean values. No differences were found concerning the PST test results while participants are still asymptomatic. Psychopathology was only present in symptomatic carriers. Conclusions: The onset of the disease seems to assume the trigger for psychological disturbance, regardless the time that has elapsed since the PST result communication or the individual carrier/non-carrier condition. Keywords: Pre-symptomatic testing, psychological impact, late-onset genetic diseases. Pruebas pre-sintomaticas de enfermedades neurodegenerativas: el impacio psicopatologico a largo plazo. Antecedentes: el presente estudio transversal investigo el impacto psicopatologico a medio (4 anos) y a largo plazo (7 y 10 anos) de la prueba pre-sintomatica (PPS) para tres enfermedades autosomicas dominantes de aparicion tardia: enfermedad de Huntington EH, la enfermedad de Machado-Joseph (EMJ) y la polineuropatia amiloide familiar (PAF). Metodo: participaron 203 sujetos: 170 (84%) realizaron el PPS para PAF, 29 (14%) para EH y 4 (2 %) para EMJ. La muestra, en su mayoria, estuvo compuesta por mujeres (58%) y por personas casadas (67%). Fueron considerados como puntos de corte los 4, 7 y 10 anos despues de haber recibido el resultado de la PPS. Resultados: las mujeres y los viudos presentan las medias mas altas. Los participantes con EMJ presentaron las medias mas elevadas. No se encontraron diferencias significativas en lo concerniente a los resultados de PPS. La perturbacion psicologica fue escasamente observada en los sujetos portadores que ya evidenciaban sintomas. Conclusiones: la aparicion de los primeras sintomas parece constituir el detonante para la existencia de perturbaciones psicologicas, independientemente del intervalo de tiempo sucedido desde la comunicacion de los resultados de la PPS o de la condicion genetica (portador/no portador). Palabras clave: prueba pre-sintomatica, impacto psicopatologico. enfermedades geneticas de aparicion tardia.</abstract><pub>Colegio Oficial De Psicologos Del Principado De Asturias</pub><doi>10.7334/psicothema2016.298</doi></addata></record>
fulltext fulltext
identifier ISSN: 0214-9915
ispartof Psicothema, 2017-10, Vol.29 (4), p.446
issn 0214-9915
language spa
recordid cdi_gale_infotracacademiconefile_A517625950
source ProQuest Central Essentials; Research Library; ProQuest Central (Alumni Edition); DOAJ Directory of Open Access Journals; ProQuest Central Student; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Research Library (Alumni Edition); Research Library Prep; ProQuest Central Korea; ProQuest Central UK/Ireland; ProQuest Central
title Pre-symptomatic testing for neurodegenerative disorders: Middle- to long-term psychopathological impact
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T01%3A51%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pre-symptomatic%20testing%20for%20neurodegenerative%20disorders:%20Middle-%20to%20long-term%20psychopathological%20impact&rft.jtitle=Psicothema&rft.au=Ledo,%20Susana&rft.date=2017-10-01&rft.volume=29&rft.issue=4&rft.spage=446&rft.pages=446-&rft.issn=0214-9915&rft_id=info:doi/10.7334/psicothema2016.298&rft_dat=%3Cgale%3EA517625950%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A517625950&rfr_iscdi=true